When is it time to stop treating radiation maculopathy? Dr. Lara Sandri (South Africa) and Dr. Rodrigo Anguita (Moorfields Eye Hospital, UK) share their highlights from the Euretina Congress in Vienna, from a five-phase model of radiation damage and the genetics that separate uveal from skin melanoma, to predicting proliferative vitreoretinopathy before it takes hold and how regulators will judge AI. The sessions are available to watch on demand.
Members can continue the conversation in the Euretina Forum.
Browse all podcast episodes here.
Listen on your preferred podcast player:
